The issue of prescription drug misuse in Finland is a complex and concerning matter that demands attention and action. While official figures estimate that around 100,000 Finns regularly abuse painkillers, the true scale of the problem may be even larger, with the Finnish Institute for Health and Welfare (THL) suggesting that around 400,000 Finns have misused controlled drugs at some point. This discrepancy highlights the need for a comprehensive approach to addressing the issue.
One of the most alarming aspects of this problem is the illegal trading of prescription drugs through messaging apps and social media. Gabapentin, for example, a medication used to treat epilepsy and nerve pain, can be sold for prices far above its pharmacy cost, indicating a thriving black market. This not only puts individuals at risk of harm due to the potential for counterfeit or contaminated drugs but also undermines the integrity of the healthcare system.
The role of doctors in this context is particularly concerning. Yle's findings suggest that some doctors may be enabling misuse through lenient prescribing practices, potentially prescribing controlled medicines even in cases where substance abuse is suspected. This not only contributes to the problem but also raises ethical and legal questions about the responsibility of medical professionals.
The Finnish Supervisory Agency (LVV) has taken some steps to address this issue, revoking the rights of 14 doctors to prescribe controlled drugs last year. However, the fact that employers are expected to address concerns before cases are referred to regulators suggests that more needs to be done to prevent and detect misuse.
To combat this issue, a multi-faceted approach is necessary. Firstly, more non-pharmacological treatments for pain should be made available, alongside closer monitoring of the conditions for which narcotic medicines are prescribed. This could help reduce the demand for controlled drugs and prevent misuse. Secondly, pharmacies play a crucial role in preventing misuse. By implementing stricter protocols for dispensing controlled medications and reporting suspicious activity, they can help disrupt the black market.
In conclusion, the misuse of prescription drugs in Finland is a serious public health concern that requires a comprehensive and coordinated response. By addressing the root causes of the problem, such as making non-pharmacological treatments available and strengthening the role of pharmacies, we can work towards reducing the number of individuals who misuse controlled drugs. However, it is also important to recognize the complex interplay between medical professionals, patients, and the black market, and to take a holistic approach to tackling this issue.
